Wermer Marieke J H, Rinkel Gabriël J E, Greebe Paut, Albrecht Kees W, Dirven Clemens M, Tulleken Cees A
Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.
Neurosurgery. 2005 Feb;56(2):197-204; discussion 197-204. doi: 10.1227/01.neu.0000148894.32031.39.
Patients with subarachnoid hemorrhage (SAH) who have been successfully treated for all detected aneurysms are at risk for recurrence of SAH. We assessed the characteristics, complications of re-treatment, and outcomes of patients with recurrent SAH as important factors in determining whether to screen patients for new aneurysms.
We studied patients admitted between 1987 and 2002 to three hospitals in the Netherlands for recurrent SAH. Patients had received treatment previously for all aneurysms identified after initial SAH. We collected data for age, sex, risk factors, site, and number of the aneurysm(s), time between the first and the second SAH, complications of re-treatment, and outcome after recurrent SAH.
We identified 30 patients: 27 women and 3 men. Thirty-two aneurysms were documented; 19 were classified as de novo, 8 were classified as regrowth, and 5 had been missed in retrospect. The mean time between the first and the second SAH was 7.8 years (range, 0.25-17 yr for all aneurysms and 2.8-14 yr for de novo aneurysms). Nine patients (30%) had a family history of SAH. No specific complications were reported with reoperation in 21 patients. Ten patients (33%) died, 4 patients (14%) were severely disabled, and 16 patients (53%) had good outcomes.
Among patients admitted with recurrent SAH, there is a predominance of women and patients with familial SAH. Reoperation is not associated with specific complications. Outcome after recurrent SAH is similar to that after initial SAH.
已成功治疗所有检测到的动脉瘤的蛛网膜下腔出血(SAH)患者仍有SAH复发风险。我们评估了复发性SAH患者的特征、再次治疗的并发症及预后,这些是决定是否对患者进行新发动脉瘤筛查的重要因素。
我们研究了1987年至2002年间荷兰三家医院收治的复发性SAH患者。这些患者先前已接受过首次SAH后发现的所有动脉瘤的治疗。我们收集了患者的年龄、性别、危险因素、动脉瘤的部位和数量、首次与第二次SAH之间的时间、再次治疗的并发症以及复发性SAH后的预后数据。
我们确定了30例患者,其中27例女性,3例男性。记录到32个动脉瘤,19个被分类为新发,8个被分类为再生长,5个经回顾发现为漏诊。所有动脉瘤首次与第二次SAH之间的平均时间为7.8年(范围0.25 - 17年),新发动脉瘤为2.8 - 14年。9例患者(30%)有SAH家族史。21例患者再次手术未报告特定并发症。10例患者(33%)死亡,4例患者(14%)严重残疾,16例患者(53%)预后良好。
在复发性SAH入院患者中,女性和家族性SAH患者占多数。再次手术与特定并发症无关。复发性SAH后的预后与首次SAH后的预后相似。